INTRODUCTION
Adriamycin is one of the most widely used of all the current, clinically useful anticancer drugs [1, 2] . Because of this clinical importance there has been an intensive effort to elucidate the mode of action of this drug, with the objective being to design improved derivatives based on a logical understanding of the receptor site [1] [2] [3] [4] [5] . Despite these efforts, the exact mode of action remains obscure, although there has been an increasing body of evidence to show that the biological activity of this compound is correlated to DNA associated events [5, 6] . For this reason, the interaction of Adriamycin with DNA has been studied in detail in recent years in order to define the DNA receptor site.
Early physico-chemical studies with synthetic polydeoxynucleotides showed that Adriamycin and daunomycin exhibited some DNA sequence preference [7] [8] [9] [10] [11] , but could not address the question of what was the most preferred site in heterogenous DNA. This question has been now partially resolved by several theoretical studies which have predicted maximal affinity of daunomycin for TpA or CpA sequences [12] or TCG and ACG sequences [13] , while for Adriamycin, ACG, ATA and TCA are possible preferred sites [14] . More recently, molecular biological approaches have yielded direct experimental evidence of the sequence specificity of daunomycin and Adriamycin. Chaires et al. [15] have used DNasel footprinting and inhibition of restriction endonucleases to show that the most preferred sites for daunomycin can be described by two adjacent GC base pairs, flanked on the 5' end by an AT base pair, while Skorobogaty et al. [16, 17] have used an in vitro transcription assay to show that Adriamycin induces transcriptional blockages immediately prior to CpA sequences.
It is clear from both theoretical and experimental studies that these drugs exhibit some sequence selectivity for DNA and that this specificity can not be adequately defined by just the two neighbouring base pairs. We have examined high affinity Adriamycin binding sites on heterogenous DNA using an in vitro transcription assay [18, 19] , and present here the first definitive analysis of the role of flanking sequences on the DNA sequence specificity of Adriamycin. Of the twelve highest affinity transcriptional blockage sites, nine occur upstream of CpA sequences, with the consensus sequence being 5'-TCA, consistent with lower drug occupancy at CpA sequences which are flanked on both ends by GC base pairs.
MATERIALS AND METHODS

Materials
Adriamycin (Ad) was a gift from Farmitalia Carlo Erba (Milan) and concentrations were determined spectrophotometrically using an extinction coefficient of 11500 M~' cm" 1 at 480 nm. E.coli RNA polymerase {E.coli RNAP) was purchased from New England Biolabs. Ultrapure ribonucleotides, 3'-0-methylnucleoside triphosphates, ApU(adenylyl(3' -5')-uridine), ApG(adenylyl (3' -5')guanosine), Ribonuclease Inhibitor (Human Placenta), BSA (RNase/DNase free) and the vector pPL-lambda were obtained from Pharmacia.
[a-
32 P]UTP and [a-32 P]ATP (3000 Ci/ml) and X-ray film (Hyperfilm-j3 max) were obtained from Amersham. Heparin was purchased from Sigma. Urea, agarose, bisacrylamide, acrylamide, ammonium persulfate, TEMED and dithiothreitol (DTT) were obtained from Biorad as electrophoresis purity reagents. Restriction endonucleases were obtained from either New England Biolabs or Boehringer-Mannheim, NA45 DEAE membrane filters were obtained through Schleicher and Schuell. The trinucleotide dGGA was synthesized on an Applied Biosystems DNA synthesizer (381-A) and used without further .purification. The riboprobe Gemini system, pGem-1 vector was obtained from Promega.
All other chemicals were analytical grade and all solutions were prepared using distilled, deionized and filtered water from a 'Milli-Q' 4 stage water purification system (Millipore).
DNA Source
A 203 bp Eco RI restriction fragment of lac DNA containing the L8-UV5 double mutant was ligated into the unique EcoRI site in the multiple cloning site of the vector pGem-1. The desired orientation was detected by restriction enzyme analysis and confirmed by RNA sequence analysis. The plasmid pPL-lambda, containing the strong leftward promoter of bacteriophage lambda, was used without further modification.
Each plasmid was transformed into E.coli cells using the calcium chloride/rubidium chloride procedure of Hanahan [20] . The recombinant pGem-1 was transformed into E.coli HB101, the pPL-lambda plasmid into E.coli N99cl + , and pBR322 into E.coli JM101. Each plasmid was then grown up in LB media containing ampicillin (50 /ig/ml) and large amounts isolated using a modification of the alkaline lysis procedure of Maniatis et al. [21] . A restriction digest of each plasmid was then performed to remove the gene for ampicillin resistance (/3-lactamase) which can potentially interfere with transcription. The recombinant pGem-1 was digested with Rsa I and the 1928 bp fragment containing the L8-UV5 promoter isolated. The pPL-lambda plasmid was digested with Bam HI to yield a 1132 bp fragment containing the XPL-promoter, while pBR322 was digested with Eco RI and Bam HI to yield a 377 bp fragment containing the tetracycline resistance promoter.
The fragments were electrophoresed onto NA45-DEAE paper, purified and concentrations determined spectrophotometrically as described previously [19] . The relevant DNA sequences of the promoters are shown in Table 1 . The L8UV5 and XPL promoters were initiated from the +1 position, while the tetracycline resistance promoter was initiated from the -1 position. 
In vitro Transcription
Transcription conditions were based on the previously published procedures [18, 19, 22] . The binary DNA/enzyme complex was formed by incubating one of the restriction fragments (50 nM) containing the desired promoter, with E.coli RNA polymerase (100 nM) for 15 min at 37°C in transcription buffer (Tc). The Tc buffer contained 40 mM Tris.HCl (pH = 8.0), 100 mM KC1, 3 mM MgCl 2 , 0.1 mM EDTA, 10 mM DDT, 125 /xg/ml BSA and 1.6 u/^1 RNase inhibitor. Heparin was then added (final concentration of 400 /*g/ml) and the mixture incubated for 5 min at 37 °C. A stable ternary complex was then formed (consisting of DNA, RNA polymerase and nascent RNA of varying lengths) upon addition of the required dinucleotide (or deoxytrinucleotide), together with 3 nucleotides and a labelled nucleotide. This mixture was incubated at 37°C for 10 min. The nucleotides and labelled nucleotides used for each an elongation nucleotide mix containing UTP, CTP, ATP, GTP (final concentration 2.5 mM) in Tc buffer and incubation continued at 10°C. Aliquots were removed at various time intervals and added to an equal volume of loading termination buffer (10 M urea, 10% sucrose, 40 mM EDTA, 0.1 % xylene cyanol, 0.1 % bromophenol blue, 0.1 % SDS in 2xTBE, pH 7.5) and placed on ice. Sequencing of the RNA was based on a modification of the method of Reisbig and Hearst (1981) involving the use of 3'-0-methyl CTP and 3'-0-methyl GTP described elsewhere [19] .
Gel Electrophoresis and Quantitation of RNA Transcripts
Electrophoresis of the RNA transcripts was performed on a Bio-Rad model 1800 sequencing apparatus at 55 °C in TBE buffer, using a 12% (w/v) or 8% (w/v) denaturing polyacrylamide gel containing 7.5 M urea, and then autoradiographed as described previously [19] . Electrophoresis was continued until the bromophenol blue had migrated to the bottom of the 12% (w/v) polyacrylamide gel, and this allowed the sequence to be read from 15 to 140 nucleotides. Electrophoresis was continued until the xylene cyanol was at the bottom of the 8% (w/v) polyacrylamide gel, and this allowed bases to be read from 70 to 200 nucleotides. Autoradiography was carried out as described previously. Autoradiographs were scanned using a Biomed model SL-504-XL laser densitometer linked to a Spectra Physics SP4270 integrator, and the area under each peak recorded as a percentage of total radioactivity in each lane. Earlier sites were analysed from the 12% (w/v) gel and later sites (>75 bp) were analysed from the 8% (w/v) gel, with the intensity of each band on the second gel being normalised with respect to corresponding bands on the first gel.
RESULTS
Adriamycin-Induced Blockages
The initiated ternary transcription complex in the absence of CTP produced a synchronised population of transcripts comprising, for the UV5 promoter for example, mainly 11-mers and 18-mers (see Table 1 ) as noted previously [19] , and there is only minor read-through to longer transcripts (Fig. 1) . These initiated complexes are stable over several hours [18, 19, 23, 24] and when elongated by high levels of all four NTP's, an increasing amount of the full length transcript is observed with increasing elongation time (Fig. 1) . Some natural pausing is evident, and the elongation conditions employed [19] minimise this previously documented phenomena [18, 19, 25] . It should be noted that since labelled nucleotides were incorporated only into the initiated complex, the intensity of each transcript is a direct measure of the relative concentration of the RNA species [19] .
When Adriamycin was present prior to elongation of the initiated complex, the sequencing gel reveals additional sequence-specific pauses which delay the build-up of full-length transcripts (Fig. 1) . These additional drug-induced pauses decay at rates comparable to those measured for the dissociation of daunomycin from DNA [26] [27] [28] [29] . This fact, together with previous observations that transcription proceeds right up to the bases comprising a drug intercalation site [18, 19, 22, 30] , confirm that these Adriamycin-induced pauses are due to the physical presence of the drug at specific sites along the transcribed DNA.
In the in vitro transcription inhibition assay employed, extremely low levels of drug will not yield detectable transcription blockage sites, whereas saturating amounts of drug will result in high occupancy of drug at every intercalation site along the DNA, and it would therefore be difficult to discriminate between low affinity and high affinity sites. For this reason, in a preliminary experiment we examined the effect of varying Adriamycin levels (1-100 fiM) on the inhibition profile. By this empirical procedure, we selected 9 /tM as the best compromise between sensitivity of detection and selectivity for high affinity sites. It is not possible to calculate an optimal drug loading since an undetermined amount of drug will be associated with the large amount of protein required in the transcription buffer [19] .
Relative Occupancy
The 45s elongation lane was scanned by laser densitometry, and the area under each band represented a fractional amount of the total label in that lane. Since the extent of label in each transcript is constant, the fractional area of each band therefore represents the mole fraction of each transcript. Natural pausing was allowed for by subtracting the mole fraction of such transcripts in the corresponding control lane. The resulting mole fractions therefore represent a measure of the relative occupancy of Adriamycin downstream of each blocked transcript [18, 19, 22] , and are shown in Fig. 2a (UV5 promoter) , Fig. 3a (XPL promoter) and Fig. 4 (Tet promoter). The relative drug occupancy at each site, as described above, does not allow for the statistical probability that even at low drug loadings, the RNA polymerase may not reach downstream drug sites on some DNA molecules if the polymerase is blocked at earlier drug sites. This factor results in a progressive under-estimation of drug occupancy at downstream sites, but can be taken into account as described previously [31] by a corrected relative occupancy (A/) defined by:
A,
where A, is the relative occupancy at the i'th drug site. An additional factor which must also be taken into account is the read-through of the RNA polymerase from one site to the next downstream site. This factor results in a decrease of band intensity at upstream sites as a function of time, and hence an increasing over-estimate of occupancies of downstream sites compared to the equilibrium distribution of drug at zero elongation time. Each site was therefore corrected for this read-through by subtracting an average decay parameter (1 -e~H) from the apparent occupancy at the i'th site, where the read-through derived from all upstream sites, as modulated by the probability that such read-through would be detected at the i'th site. As a first order approximation, the value employed for the rate constant (k) for the dissociation of Adriamycin from the DNA was the average of the first three major sites.
After these two corrections had been applied to the initial values for relative fractional occupancy, the corrected values were normalised and expressed as a fractional amount, and are shown in Figs. 2b and 3b . Because of cumulative errors inherent in these two corrections, the data have been limited to those regions where the recalculated values have an error of less than ±40%. These corrections were not applied to the occupancies deriving from the Tet promoter because natural pausing was more extensive with this system and precluded the use of the statistical and read-through corrections applied to the UV5 and \P L promoters.
In general, there are no major qualitative differences between the corrected and uncorrected data. However, for the purposes of ranking the relative occupancy at each site, the corrected data (Figs. 2b and 3b ) are more meaningful. Since the mole fraction of blocked transcripts is a measure of drug occupancy at that site [18, 19, 22, 30] , the highest occupancy sites have been selected on this basis from Figs. 2b, 3b and 4. Occupancies greater than 2.0% for the UV5 promoter and 1.5% for the XP L and Tet promoters have been used as arbitrary measures of high occupancy, and those sites satisfying these criteria have been summarised in Table 3 . Twelve high affinity sites were apparent from the total of 260 bp probed by the 3 promoter systems employed, and of these 9 contained a 5'-CA site adjacent to the transcriptional blockage site, and this preference of Adriamycin for CA sequences has been noted previously [16, 17] .
DISCUSSION
High Affinity Sites
Of the 12 high affinity sites detected by the in vitro transcription assay (Table 3 ), 9 involve a transcriptional blockage immediately prior to CpA sequences, and this identifies CpA as the highest affinity binding site for Adriamycin. These 9 sites have been summarised in Table 4 , together with their 5' and 3' flanking sequences. The most striking feature is that 7 of the 9 flanking sequences contained a T residue to the 5' side of the CpA site.
There is also a significantly greater than random occurrence of T and A residues at other sites abutting the intercalation site, and they therefore define a 6 bp consensus high affinity site as 5'-tTCA(a.t)(a.t). Since one high affinity CpA site is flanked by G on the 5' side (Table 4) , this suggests that factors other than just direct contacts from the immediate flanking sequences may be involved in defining the high affinity site.
Low Affinity CpA Sites
The implication of such a consensus sequence for high affinity binding is that the flanking sequences also contribute significantly to the thermodynamic stability of the interaction. If this is the case, then CpA sites which do not possess the optimal flanking sequences would be expected to exhibit lower affinity and hence lower occupancy. For this reason we have searched for all low occupancy CpA sequences (<0.1 %) and 11 such sites have been summarised in Table 5 . Three of these sequences contained adjacent CA palindromes, and since the low occupancy at these sites may be due to a negative cooperativity [32] , these sites have been precluded from further analysis. The remaining 8 sites are listed in Table 6 with their 5' and 3' flanking sequences. All are characterized by a high incidence of adjacent GC base pairs, and since this feature is known to be associated with rigidity of the DNA [33] , it is probable that the lack of flexibility adjacent to the intercalation site mitigates against the formation of good stabilising contact possible in more flexible sequences. The low occupancy sites are also characterised by a higher than expected distribution of GC base pairs on both sides of the CpA site, and since the consensus sequence (Table  6 ) of (g.c)CA(g.c)(g.c)(g.c) is consistent with that noted for high affinity CpA sites (Table  4) , this provides additional support for the concept of a consensus high affinity CpA binding site. 
Theoretical Studies
The systematic 4bp molecular orbital calculations of Newlin et al. [12] revealed a preference of daunomycin for (pyrimidine)p(purine) sequences. The CpA sequence was revealed as one of the highest affinity sites, and is consistent with our observations. Recent computations on the structural and energetic factors involved in the binding of daunomycin and Adriamycin to six and five hexanucleotide duplexes respectively [13, 14] revealed a preference for TCG and ACG sequences, with intercalation between the CpG base pairs. While these studies were restricted mainly to CpG and TpA as the intercalation site, and did not examine CpA sites, it did however identify three major features related to the selectivity of daunomycin-the requirement for a 5' T.A base pair adjacent to the intercalation site (G at this position gives rise to large repulsions between the G-NH 2 and the daunosamine ammonium group), the preference for C at 5'side of the intercalation site (giving rise to favourable interactions with the 9-OH of daunomycin), and the need for 3 bp to define the selectivity of the interaction. The consensus sequence of tTCA(a.t)(a.t) for high affinity binding by Adriamycin, as determined experimentally in the present work, validates all three of these theoretical predictions-a requirement for T, 5' to the intercalation site has been identified, a requirement for C as a 5' element of the intercalation site has been confirmed, and 3 bp have emerged as the dominant element of the consensus sequence. A lesser requirement for further flanking AT bp's has now also been identified, but was not considered in the theoretical analysis.
• Table 5 . Location of all low affinity CA sites with occupancy less than 0.1%. Adjacent but inverted CA sequences have been underlined. 
Promoter
Other Experimental Evidence for Specificity
The DNase I footprinting and endonuclease inhibition results of Chaires et al. [15] have been interpreted as arising from specific binding of daunomycin and Adriamycin to a triplet sequence comprising two GC base pairs flanked by an AT bp (e.g. 5'-TGG). Some of these sites therefore contain a 5'-CA element, and many of the DNase I protected regions are indeed associated with CpA sequences. The reason that other sites were identified from the DNase I footprinting may be due to the greater complexity inherent in interpretation of these results (protected sites are often broad and not clearly defined and some sequences are not probed [34, 35] ), or there may have been a higher effective drug:bp ratio than in the present transcriptional system.
X-ray Studies
Diffraction studies of a daunomycin complex with the d(CpGpTpApCpG) 2 hexanucleotide duplex have revealed an extensive and detailed understanding of the stereochemistry of the drug at its two CpG binding sites [36] [37] [38] . Most of the close van der Waals contacts Table 6 . Nucleotide sequencing flanking all low occupancy CA sites, and the concensus 5' and 3' flanking sequences. Adjacent (GO base pairs have been underlined, high probability bp shown as G.C and modest probability bp as g.c.
Promoter (<3.5 A) are with the central base pair of the ACG palindrome, and there is only one close contact to the GC on the 3' side of the CpG intercalation site. On this basis, it is likely that replacing the G of the ACG sequence with A, would retain most of the close contacts, and would be expected to be of at least similar affinity as binding to the ACG sequence. Furthermore, since the theoretical calculations clearly indicate the requirement for a A.T bp flanking the 5' side of intercalation site, and the present consensus sequence from transcription studies show experimentally that T is preferred at this site, a better sequence for future NMR and X-ray diffraction studies of the stereochemistry of the highest affinity daunomycin-DNA and Adriamycin-DNA complexes is d(TGATCA). To ensure that end effects are not a major perturbing factor, this model sequence should be extended by one or two bp at both ends, and based on the present consensus sequence, would be for example, dfTATTGATC AATA].
Biological Implications
Although the mode of action of the anthracycline class of antibiotics remains unresolved, the increasing body of evidence continues to suggest that it is at the DNA level. The question which then arises is how does the TCA sequence selectivity of these drugs contribute to their biological activity. Earlier thoughts of their effect on the B-Z transition of alternating (CA) n tracts in DNA domains in eukaryotes or their effect on regulatory CAC elements [ 17] now seem unlikely given the present evidence for the preference for TCA sequences. More likely, the drug is localised preferentially in specific control regions of the genome, with these regions possibly containing a TCA sequence (as in a promoter site) or repeated TCA elements (as in an enhancer region), with the effect on regulation of transcription arising from subtle conformational changes induced in the flanking DNA sequence.
CONCLUSIONS
The highest affinity site of Adriamycin on heterogenous DNA is 5'-TCA with intercalation between C and A. There is a lesser requirement for additional flanking A.T base pairs, with a probable highest affinity site being defined by the hexanucleotide (a.t)TCA(a.t)(a.t). Low affinity CpA sites exhibit the self-consistent flanking sequence (G.C)CA(g.c)(g.c).
